Literature DB >> 30388062

Correlation of L-Dex Bioimpedance Spectroscopy with Limb Volume and Lymphatic Function in Lymphedema.

Christopher J Coroneos1, Franklin C Wong2, Sarah M DeSnyder3, Simona F Shaitelman4, Mark V Schaverien1.   

Abstract

Background: Bioimpedance spectroscopy (BIS) is an established tool for the measurement of extracellular fluid in lymphedema. This study assesses the validity of BIS measurements using the l-Dex® for evaluating the effectiveness of interventions to treat lymphedema. Measurements are correlated with limb volume, assessment of pitting edema, physiologic measures of lymphatic function, and response to surgical intervention. Three l-Dex BIS metrics are compared. Methods and
Results: This retrospective study of prospectively collected data identified consecutive patients with lymphedema. l-Dex BIS measurements, limb volume measurements using perometry, transport index (TI) evaluation using radioisotope lymphoscintigraphy, staging using indocyanine green (ICG) fluorescent lymphography, and clinical evaluation of degree of pitting edema were compared to examine correlations. l-Dex BIS metrics included the l-Dex ratio, absolute difference between the affected and unaffected extremities, and their unadjusted ratio. The study included 26 patients with 70 sets of evaluations. There were significant correlations between the l-Dex ratio and limb volume ratio (LVR) using perometry, the degree of pitting edema, TI evaluation using lymphoscintigraphy, and staging using ICG lymphography. Of the l-Dex BIS metrics, the l-Dex ratio correlated most closely with all measures (ρ = 0.71-0.94, p < 0.0001). Following complete decongestive therapy, the mean decrease in the l-Dex ratio was 48.3% whereas the corresponding mean reduction in limb volume was 13.8% (ρ = 0.19; p = 0.65); subsequent physiological surgery including lymphovenous bypass and vascularized lymph node transfer resulted in an average reduction in l-Dex ratio of 36.1% and mean limb volume reduction of 25.2% (ρ = 0.38; p = 0.27). Conclusions: L-Dex BIS measurements demonstrate face, construct, and criterion validity, and correlate with clinical assessment, LVR, physiologic measures of lymphatic function, and response to conservative and surgical intervention. The L-Dex ratio correlates most closely with all measures and is the recommended metric when using BIS.

Entities:  

Keywords:  bioimpedence spectroscopy; indocyanine green fluorescent lymphography; lymphedema; lymphoscintigraphy; perometer

Mesh:

Year:  2018        PMID: 30388062     DOI: 10.1089/lrb.2018.0028

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  5 in total

1.  The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements.

Authors:  Pınar Borman; Ayşegül Yaman; Lütfi Doğan; Ayşe Arıkan Dönmez; Esra Gizem Koyuncu; Ayşegül Balcan; Sercan Aksoy; Cihangir Özaslan; Rabiye Akın; Kaniye Üneş
Journal:  Eur J Breast Health       Date:  2022-04-01

2.  The efficacy of different bandaging methods in patients with breast cancer-related lymphedema: A prospective, randomized study.

Authors:  Ayşegül Yaman; Pınar Borman; Adeviye İnanlı; Fatma Kul; Sevilay Karahan
Journal:  Turk J Phys Med Rehabil       Date:  2021-05-25

3.  Determination of Bioelectrical Impedance Thresholds for Early Detection of Breast Cancer-related Lymphedema.

Authors:  Siyao Liu; Quanping Zhao; Xinmei Ren; Ying Cui; Houpu Yang; Siyuan Wang; Miao Liu; Shu Wang
Journal:  Int J Med Sci       Date:  2021-06-11       Impact factor: 3.738

4.  Building a Multidisciplinary Comprehensive Academic Lymphedema Program.

Authors:  Mark V Schaverien; Donald P Baumann; Jesse C Selber; Edward I Chang; Matthew M Hanasono; Carrie Chu; Summer E Hanson; Charles E Butler
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-03-20

5.  The Effect of Acupuncture in Breast Cancer-Related Lymphoedema (BCRL): A Systematic Review and Meta-Analysis.

Authors:  Tsai-Ju Chien; Chia-Yu Liu; Ching-Ju Fang
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.